Pricing

Disc Medicine Inc (IRON)

followers ยท
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Georges Gemayel
Employees: 30
Web site: geminitherapeutics.com
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
(617) 674-9274

Are you looking for this stock instead?

Stock Split History
Date Ratio
2022-12-30 1:30
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Gemini Therapeutics, Inc. engages in developing therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) Its lead candidate is GEM103, a recombinant form of the human complement factor H protein. The company also develops GEM307 for treatment of systemic diseases.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available